The Christie NHS Foundation Trust clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 100 studies whose lead sponsor is The Christie NHS Foundation Trust. 25 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 8, 2026.
Keep track of what changes. Save the The Christie NHS Foundation Trust studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions The Christie NHS Foundation Trust leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 100. Browse all 100 →
- Preoperative Preradiotherapy TTFieldsRecruitingNCT06136611Not applicable
- Enabling Genomic Testing in Cancer of Unknown PrimaryRecruitingNCT06695494
- Using Red Light Therapy to Ease Skin Side Effects and Mouth Side Effects, in Children and Young People Aged 0 to 16 Years Old, Receiving RadiotherapyNot yet recruitingNCT07183267Not applicable
- Investigation of the ROle of faT and inflAmmaTory Cells in mElanomaNot yet recruitingNCT07293598
- A Phase III Randomised Control Clinical Trial of Radiotherapy With Radiosensitisation Versus Intravesical Bacillus Calmette-Guerin Therapy for High-risk Non-muscle Invasive Bladder Cancer.Not yet recruitingNCT07268339Phase 3
- To Determine Whether it is Feasible to Treat Patients Requiring Urgent Radiotherapy Diagnosed With Metastatic Cord Compression (MSCC) on the Magnetic Resonance Linear Accelerator (MRL) in a Single Appointment and Compare it to the Standard of Care Radiotherapy PathwayRecruitingNCT06965101Not applicable
- A Feasibility Study of MRI Guided Stereotactic Ablative Radiotherapy (MIDSECTION)RecruitingNCT05903430
- MRI Development for Radiotherapy Planning and Delivery in Non-Patient VolunteersRecruitingNCT04749134
- Pencil Beam Scanning Proton Beam Radiotherapy for the Management of Abdominal NeuroblastomaNot yet recruitingNCT06804447Not applicable
- Molecular Characterisation of Colorectal Cancer Peritoneal MetastasesRecruitingNCT05513716
- Molecular Characterisation of Appendiceal CancerRecruitingNCT05364788
- Chronic Radiation Induced Bowel Toxicity StudyRecruitingNCT06640959
- Introduction of Y90-PET-CT Post Radioembolisation Therapy ScansRecruitingNCT06123676Not applicable
- Investigating the Role of Adjuvant Proton Beam Therapy in Patients With Parotid CarcinomaNot yet recruitingNCT06421649Not applicable
- Evaluation of Combined Modality Protons and Hepatic Transplantation for Hilar CholangiocarcinomaNot yet recruitingNCT06434493Not applicable
- Exploratory Study of EBV DNA Titre Clearance Whilst on Proton Beam TherapyNot yet recruitingNCT06480903
- Circulating Tumour DNA Guided Adaptive BRAF and MEK Inhibitor TherapyNot yet recruitingNCT06470880Phase 2
- The CASCADE ProjectNot yet recruitingNCT06117592
- Musculoskeletal Health in Adult Haematological Cancer SurvivorsRecruitingNCT05865678
- Tumour Characterisation to Guide Experimental Targeted Therapy - NationalRecruitingNCT04723316
- PreOperative Brain Irradiation in GlioblastomaRecruitingNCT03582514Phase 1
- Assessing the Relationship Between Hypoxia and the Immune Environment in Myeloma Patients (CHIME)Not yet recruitingNCT06007989
- The Use and Development of Patient Reported Outcome Measures (PROMs) in the Adoptive Cell Therapy (ACT) SettingRecruitingNCT05721365
- Anorexia iN Cancer Patients: ANCHORRecruitingNCT04791254
- Serial Tumour Biopsies and Blood Biomarkers in MelanomaRecruitingNCT04493723
- PatIent exPeRiences and prEFerence of trEatment foR Multiple MyelomaCompletedNCT06322927
- NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNtsCompletedNCT04960059
- A Proof of Concept Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast CancerWithdrawnNCT04188119Phase 2
- Personalised Disease Monitoring in Metastatic Breast CancerActive, not recruitingNCT04597580
- Radial Artery AccessCompletedNCT05768412
- Pragmatic Analysis of Complex Radiotherapy Cases In Cancer of the LungActive, not recruitingNCT07202260
- Quantification of Abdominal Organ Motion Using MRICompletedNCT04748094
- Effect of Pelvic Radiotherapy on the Intestinal Microbiome and MetabolomeCompletedNCT04995809
- Circulating Tumour DNA guidEd Therapy for Stage IIB/C mElanoma After surgiCal resecTIONTerminatedNCT04901988Phase 2/3
- Remote Monitoring of Patients at Risk of SepsisWithdrawnNCT04260230Not applicable
- Second-line Therapy for Patients With Progressive Poorly Differentiated Extra-pulmonary Neuroendocrine CarcinomaCompletedNCT03837977Phase 2
- The Psychological Impact of COVID-19 on Patients with Solid Malignancies: a Single-Institution Survey StudyCompletedNCT05359718
- Lung Screening in People Cured of Hodgkin LymphomaCompletedNCT04986189Not applicable
- Carcinoma of Unknown Primary (CUP): a Comparison Across Tissue and Liquid BiomarkersCompletedNCT04750109
- Development and Validation of a Patient Reported Experience Measure for Experimental Cancer MedicineCompletedNCT05386602
- Impact of COVID-19 on Lung Cancer PatientsCompletedNCT04538456
- Upper GI Serial Tumour BiopsiesSuspendedNCT05233007
- Bone Toxicity Following Pelvic RadiotherapyActive, not recruitingNCT04555317Not applicable
- PDAC Peripheral and Portal Vein SamplingCompletedNCT04289961Not applicable
- Pancreatic Cancer Dietary Assessment StudyCompletedNCT03616431
- CAcTUS - Circulating Tumour DNA Guided SwitchActive, not recruitingNCT03808441Phase 2
- ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract CancersCompletedNCT02351765Phase 1
- Dual REctcal Angiogenesis or MEK Inhibition radioTHERAPY TrialTerminatedNCT01160926Phase 1
- TIL Therapy in Metastatic Melanoma and IL2 Dose AssessmentTerminatedNCT01995344Phase 2
- A Phase I Study of CD19 Specific T Cells in CD19 Positive MalignancyTerminatedNCT01493453Phase 1